Page last updated: 2024-08-18

pyrroles and phenformin

pyrroles has been researched along with phenformin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Inoue, T; Kira, K; Nagakura, T; Saeki, T; Tanaka, I; Yamazaki, K; Yasuda, N	1
Hasinoff, BB; O'Hara, KA; Patel, D	1

Other Studies

2 other study(ies) available for pyrroles and phenformin

Article	Year
Enhanced secretion of glucagon-like peptide 1 by biguanide compounds. Biochemical and biophysical research communications, 2002, Nov-15, Volume: 298, Issue:5 Topics: Animals; Biguanides; Buformin; Dipeptidyl Peptidase 4; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Hypoglycemic Agents; In Vitro Techniques; Male; Metformin; Peptide Fragments; Phenformin; Protease Inhibitors; Protein Precursors; Pyrroles; Rats; Rats, Inbred F344; Valine	2002
Mechanisms of myocyte cytotoxicity induced by the multiple receptor tyrosine kinase inhibitor sunitinib. Molecular pharmacology, 2008, Volume: 74, Issue:6 Topics: Acetyl-CoA Carboxylase; Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Animals, Newborn; Antineoplastic Agents; Apoptosis; Cells, Cultured; Hypoglycemic Agents; Indoles; L-Lactate Dehydrogenase; Metformin; Muscle Cells; Oxidative Stress; Phenformin; Phosphorylation; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Ribosomal Protein S6 Kinases, 90-kDa; Sunitinib	2008

Article

Year

Enhanced secretion of glucagon-like peptide 1 by biguanide compounds.

Biochemical and biophysical research communications, 2002, Nov-15, Volume: 298, Issue:5

Topics: Animals; Biguanides; Buformin; Dipeptidyl Peptidase 4; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Hypoglycemic Agents; In Vitro Techniques; Male; Metformin; Peptide Fragments; Phenformin; Protease Inhibitors; Protein Precursors; Pyrroles; Rats; Rats, Inbred F344; Valine

2002

Mechanisms of myocyte cytotoxicity induced by the multiple receptor tyrosine kinase inhibitor sunitinib.

Molecular pharmacology, 2008, Volume: 74, Issue:6

Topics: Acetyl-CoA Carboxylase; Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Animals, Newborn; Antineoplastic Agents; Apoptosis; Cells, Cultured; Hypoglycemic Agents; Indoles; L-Lactate Dehydrogenase; Metformin; Muscle Cells; Oxidative Stress; Phenformin; Phosphorylation; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Ribosomal Protein S6 Kinases, 90-kDa; Sunitinib

2008